Elutia, Inc. (ELUT)
0.8392
+0.02
(+2.34%)
USD |
NASDAQ |
Nov 16, 13:31
Elutia Price to Book Value : 2.431 for Nov. 16, 2026
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| November 13, 2026 | 2.376 |
| November 12, 2026 | 2.546 |
| November 11, 2026 | 2.665 |
| November 10, 2026 | 2.703 |
| November 09, 2026 | 2.422 |
| November 06, 2026 | 2.426 |
| November 05, 2026 | 2.175 |
| November 04, 2026 | 2.201 |
| November 03, 2026 | 2.356 |
| November 02, 2026 | 2.378 |
| October 30, 2026 | 2.425 |
| October 29, 2026 | 2.357 |
| October 28, 2026 | 2.433 |
| October 27, 2026 | 2.332 |
| October 26, 2026 | 2.312 |
| October 23, 2026 | 2.426 |
| October 22, 2026 | 2.496 |
| October 21, 2026 | 2.384 |
| October 20, 2026 | 2.348 |
| October 19, 2026 | 2.362 |
| October 16, 2026 | 2.300 |
| October 15, 2026 | 2.285 |
| October 14, 2026 | 2.129 |
| October 13, 2026 | 2.24 |
| October 12, 2026 | 2.28 |
| Date | Value |
|---|---|
| October 09, 2026 | 2.384 |
| October 08, 2026 | 2.397 |
| October 07, 2026 | 2.376 |
| October 06, 2026 | 2.251 |
| October 05, 2026 | 2.380 |
| October 02, 2026 | 2.256 |
| October 01, 2026 | 2.318 |
| September 30, 2026 | 2.289 |
| September 29, 2026 | 2.219 |
| September 28, 2026 | 2.278 |
| September 25, 2026 | 2.306 |
| September 24, 2026 | 2.334 |
| September 23, 2026 | 2.442 |
| September 22, 2026 | 2.279 |
| September 21, 2026 | 2.400 |
| September 18, 2026 | 2.391 |
| September 17, 2026 | 2.391 |
| September 16, 2026 | 2.278 |
| September 15, 2026 | 2.250 |
| September 14, 2026 | 2.208 |
| September 11, 2026 | 2.278 |
| September 10, 2026 | 2.251 |
| September 09, 2026 | 2.250 |
| September 08, 2026 | 2.334 |
| September 04, 2026 | 2.310 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Agenus, Inc. | -- |
| Amgen, Inc. | 17.59 |
| Anika Therapeutics, Inc. | 1.265 |
| BioCryst Pharmaceuticals, Inc. | -- |
| Imunon, Inc. | 1.476 |
Price to Book Value Related Metrics
| PS Ratio | 3.675 |
| Price | 0.8392 |
| Earnings Yield | -75.26% |
| Market Cap | 37.26M |